rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2001-8-6
|
pubmed:abstractText |
alpha4 integrins are important mediators of leukocyte migration across vascular endothelium. This pilot placebo-controlled study aimed to assess the safety and efficacy of natalizumab, a recombinant humanized monoclonal antibody to alpha4 integrin, in patients with mild to moderately active Crohn's disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0016-5085
|
pubmed:author |
pubmed-author:AllisonM CMC,
pubmed-author:AmlotP LPL,
pubmed-author:DonoghueSS,
pubmed-author:FouweatherM GMG,
pubmed-author:GordonF HFH,
pubmed-author:GreenleesCC,
pubmed-author:HamiltonM IMI,
pubmed-author:LaiC WCW,
pubmed-author:PounderR ERE,
pubmed-author:SrivastavaE DED,
pubmed-author:SubhaniJJ
|
pubmed:issnType |
Print
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
268-74
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11487536-Adult,
pubmed-meshheading:11487536-Antibodies, Monoclonal,
pubmed-meshheading:11487536-Antigens, CD,
pubmed-meshheading:11487536-Biological Markers,
pubmed-meshheading:11487536-Crohn Disease,
pubmed-meshheading:11487536-Double-Blind Method,
pubmed-meshheading:11487536-Female,
pubmed-meshheading:11487536-Humans,
pubmed-meshheading:11487536-Integrin alpha4,
pubmed-meshheading:11487536-Male,
pubmed-meshheading:11487536-Middle Aged,
pubmed-meshheading:11487536-Quality of Life,
pubmed-meshheading:11487536-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease.
|
pubmed:affiliation |
Centre for Gastroenterology, Department of Medicine, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, England. fionagordon@ownhomeline.freeserve.co.uk
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|